Frisco’s Soleo Health Gains Specialty Pharmacy Accreditation With Distinction in Rare Disease and Orphan Drugs

Only five other U.S. companies have received ACHC accreditation as specialized pharmacies with distinction in rare disease and orphan drugs. Founded in 2014, Soleo debuted on the Inc. 5000 for the first time in 2020 and made the list again last year at No. 2352.

Soleo Health, a Frisco-based pharmacy services provider, has joined only five other U.S. companies as an Accreditation Commission for Health Care (ACHC)-accredited specialty pharmacy with distinction in rare disease and orphan drugs.

The accreditation process included audits of Soleo Health’s policies and procedures, compliance checks, and analysis of training tools, along with an evaluation of its patient protocols and delivery of care processes.

The company says the ACHC accreditation validates its commitment to high performance and patient care standards. Four of its locations—Chicago, Philadelphia, Phoenix, and Columbus, Ohio—all earned the accreditation. These pharmacies have national reach through Soleo’s pharmacy licensure in all 50 states.

Soleo Health CEO Drew Walk. [Photo: Soleo Health]

“This accreditation is indicative of our abilities to consistently strive to exceed the expectations of our stakeholders, including patients, providers, manufacturers and payors,” said Drew Walk, Soleo Health’s CEO, in a statement. “We are honored to be recognized by the ACHC with this prominent distinction, which demonstrates our unrelenting commitment to care.”

Accolades and new services

Along with its ACHC accreditation, Soleo Health has also gained notice from business media. It debuted on the Inc. 5000 list in 2020 and made the list again last year, at No. 2352. Walk says the ranking acknowledges Soleo’s substantial growth since its founding in 2014, and is evidence of the commitment of his entire organization.

One arm of Soleo’s growth is establishing Therapeutic Care Management Centers to treat and support rare- and ultra-rare-disease patients with specialty pharmaceuticals. The treatment is delivered by specially trained interdisciplinary teams including therapy-care pharmacists, registered nurses, reimbursement specialists, and patient care ambassadors.

Soleo’s specialties include amyotrophic lateral sclerosis (ALS), thyroid eye disease (TED), hemophilia, muscular dystrophy and myasthenia gravis. The firm has 20 US locations and national nursing coverage pharmacy licensure.

ACHC’s program director, Jon Pritchett, said that Soleo is recognized nationally for solutions that enhance specialty pharmacy services and improve clinical outcomes.

“Achieving ACHC Accreditation confirms their dedication to excellence,” Pritchett said in the statement.

Get on the list.
Dallas Innovates, every day.

Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.

One quick signup, and you’re done.

R E A D   N E X T